Canada Animal Vaccine Market to Reach $23,604.7 million in 2035, Growing at 6.8% CAGR

Canada Animal vaccine market valued at $12,306.8 million in 2025 and is projected to reach $23,604.7 million by 2035, growing at a CAGR of 6.8% during the forecast period (2026-2035). The market comprises preventive biological products developed for livestock and companion animals to control infectious diseases and improve herd productivity. Key product segments include porcine vaccines, poultry vaccines, livestock vaccines (including cattle and small ruminants), aquaculture vaccines, companion animal vaccines, and other specialty animal vaccines. The Canadian market is experiencing steady growth supported by rising livestock production, strong export orientation of meat and dairy products, and stringent animal health regulations. Canada’s cattle population exceeds 11 million head, while the poultry sector produces over 1.6 billion kilograms of chicken annually, creating sustained demand for preventive vaccination programs. In addition, the growing companion animal population—estimated at over 8 million dogs and 8.5 million cats—continues to drive demand for routine and advanced vaccines.

Browse the full report description of “Canada Animal Vaccine Market Size, Share & Trends Analysis Report by Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/canada-animal-vaccine-market

Government-supported animal health surveillance, biosecurity initiatives, and disease control programs further strengthen the market outlook. Agencies such as the Canadian Food Inspection Agency and the Public Health Agency of Canada play critical roles in zoonotic disease monitoring, regulatory approvals, and vaccination strategy implementation. The country’s emphasis on preventing transboundary animal diseases such as avian influenza and African swine fever continues to stimulate vaccine procurement and stockpiling activities.

Key Statistics: Canada Animal Vaccines at a Glance

• Canada maintains more than 11 million cattle and approximately 14 million hogs, representing a substantial addressable base for livestock vaccines.
• The poultry industry processes over 800 million birds annually, reinforcing consistent demand for vaccination programs against avian diseases.
• Companion animal ownership exceeds 16 million pets nationwide, supporting steady growth in preventive veterinary immunization.
• Federal and provincial biosecurity frameworks mandate vaccination and surveillance programs for major livestock diseases, strengthening long-term vaccine adoption.

Key Innovators Driving Canada Animal Vaccine Transformation

The key players in the Canada animal vaccine market include Boehringer Ingelheim GmbH, Elanco Animal Health Incorporated, Merck & Co., Inc., Phibro Animal Health Corporation, Zoetis Inc, among others.

• In May 2025, Zoetis expanded its biologics portfolio in Canada with additional livestock and companion animal vaccine products intended to support disease prevention programs.
• In March 2025, Boehringer Ingelheim reported developments in recombinant and vectored vaccine technologies for the North American market, including Canada, with a focus on immunogenic response and manufacturing efficiency.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By Technology
• Competitive Landscape - Boehringer Ingelheim GmbH, Elanco Animal Health Incorporated, Merck & Co., Inc., Phibro Animal Health Corporation, Zoetis Inc, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Canada Animal Vaccine Market Report Segment

By Type

• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines
• Aquaculture Vaccines
• Companion Animal Vaccines
• Other

By Technology

• Live Attenuated Vaccine
• Killed/Inactive Vaccine
• Recombinant Vaccine
• Vectored Vaccine
• Subunit Vaccine
• DNA Vaccine
• Chimeric Vaccine
• Others

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/canada-animal-vaccine-market